1. Purpose

The Risk Appetite Statement defines the level and types of risk Slate Blue Capital is willing to accept in pursuit of its strategic objectives. The Statement reflects the firm's commitment to durable capital, conservative leverage, real collateral, and transparent governance, and serves as a binding constraint on investment, financing, and operating decisions across the platform.

2. Risk Philosophy

The firm seeks to compound durable capital across real assets, credit, and adjacent private markets through long-duration ownership of high-quality assets supported by conservative assumptions and real collateral. The firm accepts business and investment risk in pursuit of risk-adjusted returns. The firm does not accept governance risk, control risk, or reputational risk inconsistent with its standing with limited partners and regulators.

3. Governance

The Risk function is led by the Chief Risk Officer. The Chief Risk Officer is structurally independent of investment teams, reports to the Chief Executive Officer, and has a dotted line to the Audit Committee. The Risk function maintains veto rights on covenant terms, concentration exposures, and counterparty selections that exceed defined thresholds. Risk review is a required input to every Investment Committee decision.

4. Quantitative Limits

Leverage. Total platform leverage is governed by per-strategy targets that reflect the cash flow, collateral, and liquidity characteristics of each asset class. Real asset strategies operate to conservative loan-to-value ratios calibrated to property type, market, and stabilization. Credit strategies apply leverage consistent with the risk profile of the underlying portfolio. Use of fund-level subscription lines is limited and disclosed.

Concentration. No single position shall exceed defined percentages of total fund commitments without Risk Committee approval and, where required by fund governing documents, Limited Partner Advisory Committee consent. Sector, geographic, and counterparty concentration limits apply at both the fund and platform levels.

Counterparty. Counterparty exposure (lenders, hedging counterparties, trading counterparties, derivative counterparties) is monitored against minimum credit quality and maximum exposure limits. Concentration to any single counterparty is bounded both in absolute terms and as a percentage of total counterparty exposure.

Liquidity. Each fund maintains liquidity sufficient to meet operating cash needs, capital calls of co-invested vehicles, and reasonably foreseeable capital requirements. Platform-level liquidity is stress-tested quarterly under defined adverse scenarios.

5. Qualitative Limits

The firm will not invest in: (a) businesses whose primary economic value depends on regulatory arbitrage subject to material adverse change; (b) businesses with material unresolved governance, accounting, or compliance issues; (c) counterparties on the firm's restricted list; (d) sectors expressly excluded by the firm's Responsible Investment framework. The firm requires real collateral, contractually documented cash flows, or established operating history as the foundation of investment underwriting in real asset strategies.

6. Monitoring Cadence

Weekly Risk Review. The Chief Risk Officer convenes a weekly review of new transactions, covenant developments, counterparty exposures, and market signals. Outputs are distributed to the Investment Committee and the CFO.

Monthly Firm Risk Report. A consolidated report covering exposure, leverage, concentration, counterparty, liquidity, and emerging risk topics is delivered to the Investment Committee, the CFO, and the Audit Committee Chair.

Quarterly Concentration and Covenant Review. A comprehensive review of concentration limits and active covenants across the platform, with proposed mitigations for any limit approaches.

Pre-Investment Committee Risk Memo. A standing Risk Memo accompanies every Tier 3 or Tier 4 investment proposal (proposals above the per-strategy threshold) and articulates Risk's view on the transaction's exposure to defined risk factors.

Annual restatement. The Risk Appetite Statement is restated annually based on platform composition, market conditions, and prior-period observations.

7. Risk Veto Rights

The Chief Risk Officer holds veto rights on: (a) covenant terms that fall below defined minimum standards; (b) concentration exposures that exceed defined thresholds; (c) counterparty selections that fall below defined credit quality or that breach exposure limits. Veto decisions are documented and may be overridden only by the Investment Committee acting unanimously, with Audit Committee notification.

8. Escalation

Risk concerns that cannot be resolved at the Investment Committee or platform leadership level escalate to the Chief Executive Officer and, in matters affecting the integrity of the firm's controls, to the Audit Committee. Limited partners may raise risk concerns directly to the Chief Risk Officer, the Audit Committee Chair, or through the channels described in the Whistleblower Policy.

9. Stress Testing

The firm performs quarterly platform-level stress tests under defined adverse scenarios, including interest rate shocks, credit spread widening, real estate value declines, energy price shocks, and counterparty failure. Results are reported to the Investment Committee, the CFO, and the Audit Committee.

10. Reporting

The Risk Appetite Statement and any material changes are disclosed to limited partners through fund offering documents and periodic communications. Limited partners may request the full Statement and supporting risk reports from the Chief Risk Officer.